Publicaciones en colaboración con investigadores/as de KU Leuven (7)

2011

  1. Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

    Osteoporosis International

2009

  1. Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled european study of forsteo (EUROFORS)

    Journal of Bone and Mineral Research, Vol. 24, Núm. 4, pp. 726-736

2008

  1. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 3, pp. 852-860

  2. Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment

    Journal of Bone and Mineral Research, Vol. 23, Núm. 10, pp. 1591-1600

2007

  1. Teriparatide or alendronate in glucocorticoid-induced osteoporosis

    New England Journal of Medicine, Vol. 357, Núm. 20, pp. 2028-2039

2006

  1. Reply by Boonen et al. [17]

    Journal of the American Geriatrics Society

  2. Safety and efficacy of teriparatide in elderly women with established osteoporosis: Bone anabolic therapy from a geriatric perspective

    Journal of the American Geriatrics Society, Vol. 54, Núm. 5, pp. 782-789